These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17163447)

  • 1. Genetic analysis of the innate immune responses in wild-derived inbred strains of mice.
    Stephan K; Smirnova I; Jacque B; Poltorak A
    Eur J Immunol; 2007 Jan; 37(1):212-23. PubMed ID: 17163447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
    Holm CK; Petersen CC; Hvid M; Petersen L; Paludan SR; Deleuran B; Hokland M
    J Immunol; 2009 Oct; 183(7):4422-31. PubMed ID: 19748983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG motifs to modulate innate and adaptive immune responses.
    Vollmer J
    Int Rev Immunol; 2006; 25(3-4):125-34. PubMed ID: 16818368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C; Vollmer J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):204-10. PubMed ID: 15603254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
    Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
    J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsins are required for Toll-like receptor 9 responses.
    Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes.
    He H; Genovese KJ; Nisbet DJ; Kogut MH
    Mol Immunol; 2007 May; 44(12):3234-42. PubMed ID: 17339052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of TLR9 activation.
    Latz E; Visintin A; Espevik T; Golenbock DT
    J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.
    Klein M; Obermaier B; Angele B; Pfister HW; Wagner H; Koedel U; Kirschning CJ
    J Infect Dis; 2008 Oct; 198(7):1028-36. PubMed ID: 18700834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
    Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9.
    Knuefermann P; Schwederski M; Velten M; Krings P; Ehrentraut H; Rüdiger M; Boehm O; Fink K; Dreiner U; Grohé C; Hoeft A; Baumgarten G; Koch A; Zacharowski K; Meyer R
    Cardiovasc Res; 2008 Apr; 78(1):26-35. PubMed ID: 18194990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Toll-like receptors 3 and 9 in the development of autoimmune diabetes in NOD mice.
    Wong FS; Hu C; Zhang L; Du W; Alexopoulou L; Flavell RA; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():146-8. PubMed ID: 19120284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
    Peter ME; Kubarenko AV; Weber AN; Dalpke AH
    J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the development of immunostimulatory oligonucleotides.
    Uhlmann E; Vollmer J
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):204-17. PubMed ID: 12669456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.